Last Updated : February 9, 2015
Details
FilesGeneric Name:
Eculizumab
Project Status:
Complete
Therapeutic Area:
Atypical hemolytic uremic syndrome
Manufacturer:
Alexion Pharma Canada
Brand Name:
Soliris
Project Line:
Reimbursement Review
Project Number:
SF0416-000
Submission Type:
Request For Advice
Indications:
Hemolytic Uremic Syndrome, Atypical
Recommendation Type:
N/A
Files
Last Updated : February 9, 2015